Immunovant, Inc.

IMVT

$24.84

Name : Immunovant, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $5,055,739,392.00

EPSttm : -2.67

Immunovant, Inc.

$24.84

5.48%

$1.29

IMVT — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

19.71

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

-0.2

EPS Last/This Y

0.2

EPS This/Next Y

-0.09

Price

24.86

Target Price

40.18

Analyst Recom

1.56

Performance Q

-3.01

Upside

-240.3%

Beta

0.71

Ticker: IMVT

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	IMVT	26.42	0.08	0.26	29389
2026-03-10	IMVT	25.73	0.08	0.00	29371
2026-03-11	IMVT	25.56	0.09	0.09	27593
2026-03-12	IMVT	25.01	0.09	0.04	27594
2026-03-13	IMVT	24.99	0.09	0.04	27594
2026-03-17	IMVT	25.1	0.09	0.14	28530
2026-03-18	IMVT	23.58	0.09	0.03	28635
2026-03-19	IMVT	23.62	0.09	0.40	28812
2026-03-20	IMVT	23.01	0.09	0.48	28820
2026-03-23	IMVT	24.39	0.08	0.17	28030
2026-03-24	IMVT	23.84	0.08	0.43	28065
2026-03-25	IMVT	24.73	0.11	11.73	31291
2026-03-26	IMVT	25.34	0.16	0.07	32721
2026-03-27	IMVT	23.98	0.16	0.10	32702
2026-03-30	IMVT	23.57	0.16	0.00	32836
2026-03-31	IMVT	24.96	0.16	0.06	33293
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

16 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	IMVT	26.40	12.2	48.1	-2.52
2026-03-10	IMVT	25.73	12.2	56.3	-2.52
2026-03-11	IMVT	25.53	12.2	46.9	-2.52
2026-03-12	IMVT	25.01	12.2	54.2	-2.52
2026-03-13	IMVT	24.41	12.2	55.2	-2.52
2026-03-17	IMVT	25.10	12.2	41.0	-2.52
2026-03-18	IMVT	23.59	12.2	75.4	-2.52
2026-03-19	IMVT	23.62	12.2	74.8	-2.52
2026-03-20	IMVT	22.98	12.2	87.9	-2.52
2026-03-23	IMVT	24.35	12.2	59.8	-2.52
2026-03-24	IMVT	23.85	12.2	69.9	-2.53
2026-03-25	IMVT	24.75	12.2	51.6	-2.53
2026-03-26	IMVT	25.38	12.2	38.8	-2.53
2026-03-27	IMVT	23.97	12.2	67.7	-2.53
2026-03-30	IMVT	23.57	12.2	75.8	-2.53
2026-03-31	IMVT	24.86	12.2	49.3	-2.53
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

16 items 1 of 1

17 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-06	IMVT	16.12	5.64	20.17
2026-03-09	IMVT	16.12	5.74	20.17
2026-03-10	IMVT	16.12	5.74	20.17
2026-03-11	IMVT	16.12	5.74	20.03
2026-03-12	IMVT	16.12	5.74	20.03
2026-03-13	IMVT	16.12	5.74	20.03
2026-03-17	IMVT	16.12	5.74	20.03
2026-03-18	IMVT	16.12	5.74	20.03
2026-03-19	IMVT	16.12	5.74	20.03
2026-03-20	IMVT	16.12	5.74	20.03
2026-03-23	IMVT	16.12	5.74	20.03
2026-03-24	IMVT	16.12	5.74	20.03
2026-03-25	IMVT	16.12	5.74	19.71
2026-03-26	IMVT	16.12	5.74	19.71
2026-03-27	IMVT	16.12	5.74	19.71
2026-03-30	IMVT	16.12	5.74	19.71
2026-03-31	IMVT	16.12	5.74	19.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

17 items 1 of 1

Last Quarter Act. EPS

-0.61

Avg. EPS Est. Current Quarter

-0.56

Avg. EPS Est. Next Quarter

-0.81

Insider Transactions

16.12

Institutional Transactions

5.74

Beta

0.71

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

45.5

Max Drawdown 5-Year %

-79.9

Target Price

40.18

P/E

Forward P/E

PEG

P/S

P/B

5.12

P/Free Cash Flow

EPS

-2.68

Average EPS Est. Cur. Y

-2.53

EPS Next Y. (Est.)

-2.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.31

Return on Equity vs Sector %

-74.5

Return on Equity vs Industry %

-58.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

49.3

◆ IMVT Healthcare

$24.84

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

16/25

Volume

3/15

Valuation

10/20

TP/AR

1/10

Options

8/10

RSI

48.7

Range 1M

17.3%

Sup Dist

5.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

10/30

Estimates

0/20

Inst/Vol

8/15

Options

8/10

EPS Yr

3.5%

EPS NY

2.3%

52W%

66.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +61.8% upside

Quality

2/30

Valuation

12/30

Growth

7/25

Stability

7/10

LT Trend

1/5

Upside

+61.8%

Quality

Immunovant, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 362

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

IMVT

Latest News

—

Caricamento notizie per IMVT…

stock quote shares IMVT – Immunovant Inc Stock Price stock today

news today IMVT – Immunovant Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch IMVT – Immunovant Inc yahoo finance google finance

stock history IMVT – Immunovant Inc invest stock market

stock prices IMVT premarket after hours

ticker IMVT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IMVT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y